Cardiovascular Revascularization Medicine
Volume 11, Issue 1 , Pages 8-19 , January 2010

Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery

  • Jeysen Zivan Yogaratnam

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom
    • Corresponding Author InformationCorresponding author. 2 Annandale Road, W4 2HF London, UK. Tel.: +44 7974214691.
    • ,
  • Gerard Laden

      Affiliations

    • North of England Hyperbaric and Medical Services, Classic Hospital, Lowfield Road, Anlaby, East Yorkshire, HU10 7AZ, United Kingdom
    • ,
  • Levant Guvendik

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom
    • ,
  • Mike Cowen

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom
    • ,
  • Alex Cale

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom
    • ,
  • Steve Griffin

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom

Received 31 December 2008 ,Revised 16 March 2009 ,Accepted 17 March 2009.

References 

  1. American Heritage Dictionary. Boston: Houghton Mifflin Co.; 1994;
  2. Morykwas MJ, Argenta LC. Nonsurgical modalities to enhance healing and care of soft tissue wounds. J South Orthop Assoc. 1997;6:279–288
  3. Kindwall EP, Whelan HT. Hyperbaric Medicine Practice. Flagstaff, AZ: Best Publishing Company; 2002;
  4. Benedetti S, Lamorgese A, Piersantelli M, Pagliarani S, Benvenuti F, Canestrari F. Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. Clin Biochem. 2004;37:312–317
  5. Gregorevic P, Lynch GS, Williams DA. Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal muscles. Eur J Appl Physiol. 2001;86:24–27
  6. Conconi MT, Baiguera S, Guidolin D, Furlan C, Menti AM, Vigolo S, et al. Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line. J Investig Med. 2003;51:227–232
  7. Yogaratnam JZ, Laden G, Madden LA, Seymour AM, Guvendik L, Cowen M, et al. Hyperbaric oxygen: a new drug in myocardial revascularization and protection?. Cardiovasc Revasc Med. 2006;7:146–154
  8. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation. 1989;80:1115–1127
  9. Kukreja RC, Hess ML. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res. 1992;26:641–655
  10. Sterling DL, Thornton JD, Swafford A, Gottlieb SF, Bishop SP, Stanley AW, et al. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation. 1993;88:1931–1936
  11. Kim CH, Choi H, Chun YS, Kim GT, Park JW, Kim MS. Hyperbaric oxygenation pretreatment induces catalase and reduces infarct size in ischemic rat myocardium. Pflugers Arch. 2001;442:519–525
  12. Han C, Lin L, Zhang W, Zhang L, Lv S, Sun Q, et al. Hyperbaric oxygen preconditioning alleviates myocardial ischemic injury in rats. Exp Biol Med (Maywood). 2008;233:1448–1453
  13. Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Can hyperbaric oxygen be used as adjunctive heart failure therapy through the induction of endogenous heat shock proteins?. Adv Ther. 2007;24:106–118
  14. Jugdutt BI. Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev. 2002;7:391–405
  15. Li W, Jia G, Guo W, Wang H. Nitric oxide opens second window of protection in ischemic preconditioning via induction of heat-shock protein 72. Chin Med J (Engl). 2003;116:258–262
  16. Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, Perez de Lema G, Rodriguez-Puyol M, Lamas S, et al. Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol. 1998;124:447–454
  17. Arnaud C, Joyeux M, Garrel C, Godin-Ribuot D, Demenge P, Ribuot C. Free-radical production triggered by hyperthermia contributes to heat stress-induced cardioprotection in isolated rat hearts. Br J Pharmacol. 2002;135:1776–1782
  18. Sharifi M, Fares W, Abdel-Karim I, Koch JM, Sopko J, Adler D. Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. Am J Cardiol. 2004;93:1533–1535
  19. Kudchodkar BJ, Wilson J, Lacko A, Dory L. Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 2000;20:1637–1643
  20. Kudchodkar BJ, Pierce A, Dory L. Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis. 2006;
  21. Shandling AH, Ellestad MH, Hart GB, Crump R, Marlow D, Van Natta B, et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the “HOT MI” pilot study. Am Heart J. 1997;134:544–550
  22. Wang X, Wei M, Kuukasjarvi P, Laurikka J, Jarvinen O, Rinne T, et al. Novel pharmacological preconditioning with diazoxide attenuates myocardial stunning in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2003;24:967–973
  23. Alex J, Laden G, Cale AR, Bennett S, Flowers K, Madden L, et al. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial. J Thorac Cardiovasc Surg. 2005;130:1623–1630
  24. Piantadosi S. Clinical Trials. In: Clinical Trials: A Methodologic Perspective. John Wiley & Sons; 1997;p. 394–396
  25. Altman D. Intention to Treat. Practical Statistics for Medical Research. Chapman & Hall; 1990;
  26. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319:670–674
  27. Molenberghs G, Kenward MG. In: Missing Data in Clinical Studies. Chichester: John Wiley & Sons Inc.; 2007;p. 504
  28. Rosenfeld R, Smith JM, Woods SE, Engel AM. Predictors and outcomes of extended intensive care unit length of stay in patients undergoing coronary artery bypass graft surgery. J Card Surg. 2006;21:146–150
  29. Nakasuji M, Matsushita M, Asada A. Risk factors for prolonged ICU stay in patients following coronary artery bypass grafting with a long duration of cardiopulmonary bypass. J Anesth. 2005;19:118–123
  30. Dekleva M, Neskovic A, Vlahovic A, Putnikovic B, Beleslin B, Ostojic M. Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. Am Heart J. 2004;148:E14
  31. Swift PC, Turner JH, Oxer HF, O'Shea JP, Lane GK, Woollard KV. Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. Am Heart J. 1992;124:1151–1158
  32. Aparci M, Kardesoglu E, Suleymanoglu S, Uzun G, Onem Y, Uz O, et al. Hyperbaric oxygen therapy improves myocardial diastolic function in diabetic patients. Tohoku J Exp Med. 2008;214:281–289
  33. Yacoub MH, Zeitlin GL. Hyperbaric oxygen in the treatment of the postoperative low-cardiac-output syndrome. Lancet. 1965;191:581–583
  34. Thurston JG, Greenwood TW, Bending MR, Connor H, Curwen MP. A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Q J Med. 1973;42:751–770
  35. De Feo M, Gregorio R, Della Corte A, Marra C, Amarelli C, Renzulli A, et al. Deep sternal wound infection: the role of early debridement surgery. Eur J Cardiothorac Surg. 2001;19:811–816
  36. Barili F, Polvani G, Topkara K, Dainese L, Cheema FH, Roberto M, et al. Role of hyperbaric oxygen therapy in the treatment of postoperative organ/space sternal surgical site infections. World J Surg. 2007;
  37. Lappa A, Malpieri MR, Cicco M, Bucci A, Malpieri M, Araimo F, et al. An alternative inexpensive treatment for deep sternal wound infections after sternotomy. Interact Cardiovasc Thorac Surg. 2003;2:629–632
  38. Petzold T, Feindt PR, Carl UM, Gams E. Hyperbaric oxygen therapy in deep sternal wound infection after heart transplantation. Chest. 1999;115:1455–1458
  39. Park MK, Myers RA, Marzella L. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin Infect Dis. 1992;14:720–740
  40. Lopez AE, Rodriguez S, Flores I. Management of ischemic hemorrhagic cystitis with hyperbaric oxygen therapy. Undersea Hyperb Med. 2001;28:35–36
  41. Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, et al. Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke. 2007;38:1362–1367
  42. Veltkamp R, Siebing DA, Sun L, Heiland S, Bieber K, Marti HH, et al. Hyperbaric oxygen reduces blood–brain barrier damage and edema after transient focal cerebral ischemia. Stroke. 2005;36:1679–1683
  43. Berg K, Haaverstad R, Astudillo R, Bjorngaard M, Skarra S, Wiseth R, et al. Oxidative stress during coronary artery bypass operations: importance of surgical trauma and drug treatment. Scand Cardiovasc J. 2006;40:291–297
  44. Berg K, Jynge P, Bjerve K, Skarra S, Basu S, Wiseth R. Oxidative stress and inflammatory response during and following coronary interventions for acute myocardial infarction. Free Radic Res. 2005;39:629–636
  45. Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S, et al. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res. 2004;38:517–525
  46. Robin E, Guzy RD, Loor G, Iwase H, Waypa GB, Marks JD, et al. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem. 2007;282:19133–19143
  47. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol. 2005;100:179–190
  48. Hegstad AC, Antonsen OH, Ytrehus K. Low concentrations of hydrogen peroxide improve post-ischaemic metabolic and functional recovery in isolated perfused rat hearts. J Mol Cell Cardiol. 1997;29:2779–2787
  49. Valen G, Skjelbakken T, Vaage J. The role of nitric oxide in the cardiac effects of hydrogen peroxide. Mol Cell Biochem. 1996;159:7–14
  50. Ytrehus K, Walsh RS, Richards SC, Downey JM. Hydrogen peroxide as a protective agent during reperfusion. A study in the isolated perfused rabbit heart subjected to regional ischemia. Cardiovasc Res. 1995;30:1033–1037
  51. Valen G, Starkopf J, Takeshima S, Kullisaar T, Vihalemm T, Kengsepp AT, et al. Preconditioning with hydrogen peroxide (H2O2) or ischemia in H2O2-induced cardiac dysfunction. Free Radic Res. 1998;29:235–245
  52. Takeshima S, Vaage J, Valen G. Can reactive oxygen species precondition the isolated rat heart against arrhythmias and stunning?. Acta Physiol Scand. 1997;161:263–270
  53. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996;97:562–576
  54. Yaguchi Y, Satoh H, Wakahara N, Katoh H, Uehara A, Terada H, et al. Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts. Circ J. 2003;67:253–258

☆ Clinical Trial registration information: URL: http://clinicaltrials.gov/ct2/show/NCT00623142?term=hyperbaric+oxygen&rank=1.

☆☆ Unique identifier: NCT00623142.

★ Funding source: Centre of Medical Excellence, Air Products Global Healthcare, Avda Tenerife 2, 28703 Madrid, Spain. Tel.: +34 629254357. Contact: Begoña Señor, M.D. Contact e-mail: senorccb@apci.com. Project Code Number: RD-06-0245.

PII: S1553-8389(09)00084-0

doi: 10.1016/j.carrev.2009.03.004

Cardiovascular Revascularization Medicine
Volume 11, Issue 1 , Pages 8-19 , January 2010

Article Tools

* Image Usage & Resolution